Related by context. All words. (Click for frequent words.) 66 Clinical Oncology 65 ASCO Breast Cancer 64 CTRC AACR San Antonio 64 AACR San Antonio 62 SABCS 62 Breast Cancer Symposium 62 Hematology ASH Annual Meeting 62 AACR NCI EORTC 61 ASH Annual Meeting 61 #th Annual Interscience 61 Transcatheter Cardiovascular Therapeutics TCT 60 Genitourinary Cancers Symposium 60 ASCO GU 60 Clinical Oncology ASCO Annual 60 Thoracic Oncology 60 Endovascular Therapy ISET 60 Clinical Oncology ASCO 59 Hematology ASH 59 Clinical Oncology Annual Meeting 59 ICAAC 59 Medical Oncology ESMO 59 Digestive Disease Week 59 Hematology Annual Meeting 58 ASCO Annual Meeting 58 ASCO Prostate Cancer 58 Gastrointestinal Cancers Symposium 58 Clinical Oncology Gastrointestinal Cancers 58 Retroviruses 58 Pediatric Academic Societies PAS 58 Cancers Symposium 58 CROI 58 Transcatheter Cardiovascular Therapeutics 57 BCIRG 57 Therapeutic Radiology 57 Antimicrobial Agents 57 Liver EASL 57 SPIRIT IV 57 Digestive Disease Week DDW 57 Society CTOS 57 ESMO 57 AACR #st Annual Meeting 57 Connective Tissue Oncology 57 #rd Annual CTRC 57 ASCO GI 57 Chicago Multidisciplinary Symposium 57 EORTC NCI AACR 57 CAPRISA 57 Arteriosclerosis Thrombosis 56 Oncology ASTRO 56 Liver Diseases AASLD 56 Annual Scientific Sessions 56 Endovascular Therapy 56 Therapeutics TCT scientific 56 Symposium SABCS 56 ADA Scientific Sessions 55 Opportunistic Infections 55 Rheumatology ACR Annual 55 Hematology 55 ECTRIMS 55 Scientific Session 55 Liver Diseases 55 Hematology Meeting 55 anastrozole 55 RTOG 55 AACR #nd Annual Meeting 55 Neurology AAN 55 ASCO Genitourinary Cancers Symposium 55 pertuzumab 55 NCCTG N# 55 AASLD 55 ASCO 55 Opportunistic Infections CROI 55 Radiation Oncology ASTRO 55 Molecular Targets 54 EORTC 54 ORAL Sync 54 Investigative Dermatology 54 Gynecologic Oncologists 54 European CanCer Organisation ECCO 54 ABCSG 54 ICAAC IDSA 54 Breast Cancer Symposium SABCS 54 st Annual Meeting 54 Neck Cancer 54 evaluating tivozanib 54 Heart Failure Society 54 Clinical Oncologists 54 Scientific Sessions 54 Hypertension ASH 54 EuroPCR 54 Clinical Cancer 53 Gastrointestinal Cancer 53 Endocrine Society #nd 53 Digestive Diseases Week 53 EASL 53 Pediatric Academic Societies 53 League Against Rheumatism 53 annual Transcatheter Cardiovascular 53 UEGW 53 American Roentgen Ray 53 cetuximab Erbitux 53 Endocrine Society #st 53 Prostate Lung Colorectal 53 AUA Annual Meeting 53 Femara letrozole 53 Neuro Oncology 53 BRIM2 53 Edge STudy 53 Mineral Research ASBMR 53 ECCMID 53 Breaking Clinical Trials 53 EORTC NCI AACR Symposium 53 EORTC NCI 53 PROSTVAC TM 53 ASBMR 53 recurrent ovarian cancer 52 Nephrology Renal Week 52 AACR Annual Meeting 52 Rheumatology Annual 52 Stent Thrombosis 52 metastatic castration resistant 52 ECCO ESMO 52 Biological Therapy 52 EVEREST II 52 olaparib 52 PERSEUS 52 Michigan Comprehensive Cancer 52 AACR 52 Chemotherapy ICAAC 52 American Urological Association 52 Endocrine Society ENDO 52 Interventional Radiology SIR 52 AAN Annual Meeting 52 NEUVENGE 52 RCW Breast Cancer 52 Lung Cancer 52 Prostate Cancer Symposium 52 teriflunomide 52 Pharmacoeconomics 52 nd Annual Meeting 52 trastuzumab 52 CTRC AACR 52 neoadjuvant therapy 52 RGB # 52 adjuvant radiation 52 recurrent malignant glioma 52 recurrent GBM 52 AHA Scientific Sessions 52 AACR NCI EORTC Molecular 52 BRIM3 52 Cancer Therapeutics 52 Gynecologic Oncology Group 52 assessing T DM1 52 Screening Trial 52 International Neuropsychological Society 52 Cell Biology ASCB 52 Clinical Microbiology 52 Therapeutics TCT 52 AVERROES 52 Therapeutic Radiation 51 Breast Surgeons ASBS 51 Vascular Biology ATVB 51 ACR ARHP 51 ENESTnd 51 Gynecological Cancer 51 Diabetes EASD 51 AACR IASLC Joint 51 PreCISe 51 th Interscience Conference 51 Gynecologic Oncology 51 oral FTY# 51 viral kinetic 51 Liver Disease 51 Neoplasia 51 CARE HF 51 HER2 positive cancers 51 Lancet Oncology 51 EULAR 51 panobinostat 51 NO# [002] 51 alvespimycin 51 Cancer Immunotherapy 51 subanalysis 51 #nd EORTC NCI 51 Acquired Immune Deficiency Syndromes 51 Interscience Conference 51 randomized Phase III 51 Tykerb 51 BR.# 51 HER2 positive metastatic breast 51 HER2 positive 51 Prostate Cancer Prevention 51 Ovarian PLCO Cancer 51 Phase III ALLEGRO 51 Malignant Mesothelioma 51 AACR Frontiers 51 Doxil ® 51 Neck Surgery Foundation 51 SWOG 51 ACRIN 51 VEITHsymposium 51 RECORD1 51 denosumab 51 placebo controlled clinical 51 Urologic Oncology 51 SCCHN 51 #th Interscience Conference 50 iPrEx 50 iniparib 50 neratinib 50 HORIZONS AMI trial 50 SCAI Annual 50 Digital Mammographic Imaging 50 CALGB 50 metastatic HRPC 50 Nephrology ASN Renal 50 radezolid 50 trastuzumab Herceptin 50 Liver Disease AASLD 50 zoledronic acid Zometa 50 Taxotere ® 50 Otology Rhinology 50 Endovascular Valve Edge 50 sipuleucel T 50 ToGA 50 hormone blockers 50 oral Xeloda 50 Glucosamine Chondroitin Arthritis 50 American Psychosomatic Society 50 huC# DM4 50 Endocrine Society Annual Meeting 50 HCV SPRINT 50 sunitinib 50 Scientific Meeting 50 Phase Ib II 50 gastrointestinal cancers 50 Medical Oncology 50 Poster Discussion 50 cediranib 50 Group RTOG 50 SPIRIT III 50 Breast Surgeons 50 decitabine 50 Breaking Clinical Trial 50 subgroup analyzes 50 SUCCEED trial 50 Late Breaker 50 LBH# 50 Prostate AdenoCarcinoma Treatment 50 Arch Surg 50 Cancer iSBTc 50 Experimental Therapeutics 50 paclitaxel eluting stents 50 CUSTOM II 50 Endocrine Society 50 ASGT 50 standard chemotherapy regimen 50 Carfilzomib 50 endocrine therapy 50 atrasentan 50 Oral Presentations 50 USpella 50 Neuro Oncology SNO 50 ARVO 50 RE LY 50 T DM1 50 FDA Oncologic Drugs 50 ongoing Phase 1b 50 phase IIb clinical 50 KRN# 50 Hematology ASH Meeting 49 relapsed ovarian cancer 49 ixabepilone 49 AACR Meeting 49 abstracts summarizing 49 docetaxel chemotherapy 49 SCD HeFT 49 enzastaurin 49 AVOREN 49 Alzheimer Disease ICAD 49 CombAT 49 ELCAP 49 Molecular Cancer 49 iSBTc 49 Phase #/#a trial 49 Genous stent 49 Human Reproduction 49 Oncology Nursing 49 multicenter trials 49 Science Translational Medicine 49 ROCKET AF 49 AIDS Vaccine 49 immunomodulatory agents 49 Clinical Chemistry AACC 49 ENDEAVOR III 49 Cardiology ESC 49 LymphoStat B 49 ACUITY trial 49 AVADO 49 CLARITY study 49 registrational Phase 49 forodesine 49 ISPOR 49 bevacizumab Avastin 49 selenium supplementation 49 resistant ovarian cancer 49 Interventional Radiology 49 PLCO 49 NSABP C 49 invasive breast cancer 49 journal Ophthalmology 49 ASTRO Annual Meeting 49 Cardiology ACC 49 Neoadjuvant 49 MERLIN TIMI 49 prostate cancer mCRPC 49 sunitinib malate 49 AP# [003] 49 Plastic Surgeons ASPS Plastic 49 TAXUS ATLAS 49 perifosine 49 Retina Specialists 49 journal Lancet Neurology 49 BIOCOM Investor Conference 49 Novartis Zometa 49 tipranavir 49 Advanced Neuroendocrine Tumors 49 ExTRACT TIMI 49 Xelox 49 relapsed MM 49 ENDEAVOR IV 49 recurrent glioblastoma multiforme 49 YONDELIS 49 Clinical Endocrinology 49 Evaluation WISE 49 Platelet Inhibition 49 phase IIIb 49 LHRH receptor positive 49 Targeted Anticancer Therapies 49 IV bisphosphonates 49 Aggressive Drug Evaluation 49 #st Annual Meeting 49 delafloxacin 49 Molecular Medicine Tri 49 Diabetologia 49 HuMax EGFr 49 Molecular Markers 49 America HFSA 49 oral ridaforolimus 49 Neurology Annual Meeting 49 Roentgenology 49 neoadjuvant treatment 49 invasive lobular carcinoma 49 www.aacr.org 49 anti angiogenic therapy 49 Gynecologic Investigation 49 DDW ® 49 Canaccord Adams Hepatitis C 48 fallopian tube carcinoma 48 Brentuximab Vedotin SGN 48 TG MV 48 Inflammatory Bowel Diseases 48 www.asco.org 48 Intervention Trial GAIT 48 galiximab 48 Tumor Microenvironment 48 Antimicrobial Chemotherapy 48 Clinical Outcomes Utilizing Revascularization 48 metastatic lung cancer 48 NSABP 48 Anesthesiologists ASA 48 HCV RESPOND 2 48 Randomized Double blind 48 Gastroenterology ACG 48 pan HDAC inhibitor 48 Interventions SCAI 48 Pharmaceutical Scientists AAPS 48 chemotherapy gemcitabine 48 Lysosomal Disease Network 48 ADVANCE PD 48 Targretin 48 ganetespib 48 Alessandro Riva 48 OncoVEX GM CSF 48 advanced adenomas 48 journal Lancet Oncology 48 proteasome inhibitor 48 journal Nature Immunology 48 Annual Transcatheter Cardiovascular 48 Cancer Epidemiol Biomarkers Prev 48 bazedoxifene conjugated estrogens 48 IMPROVE HF 48 #nd Annual Meeting 48 worsening thrombocytopenia 48 Maternal Fetal Medicine SMFM 48 IL# PE#QQR 48 Clinical Trial Results 48 HER2 positive tumors 48 Cancer Therapy 48 ABRF 48 pancreatic adenocarcinoma 48 Velcade bortezomib 48 Taxotere R 48 Phase III AFFIRM 48 evaluating mipomersen 48 Cachexia 48 HER2 positive breast cancer 48 prospective multicentre 48 entecavir 48 rosuvastatin Crestor 48 Avastin bevacizumab 48 GRN#L 48 standard chemotherapy regimens 48 sorafenib tablets 48 relapsed multiple myeloma 48 ALS MND 48 Experimental Neurology 48 drug eluting stents 48 Gynecologic Cancer Society 48 Vascular Annual Meeting 48 KRAS status 48 mycophenolate mofetil 48 RE LY trial 48 Clinical Oncology JCO 48 cetuximab 48 Circulation Heart Failure 48 Stem Cell Research ISSCR 48 abiraterone 48 aromatase inhibitor anastrozole 48 endometrial cancers 48 prostate cancer CRPC 48 NEVO RES 48 COU AA 48 Rheumatology 48 journal Hepatology 48 Bortezomib 48 Abstract # 48 Neuroendocrine Tumor 48 Medicine NEJM 48 Combination REOLYSIN R 48 BIO InvestorForum 48 pCR 48 ONTARGET 48 ILLUMINATE 48 fosbretabulin 48 aflibercept 48 Maternal Fetal Medicine 48 journal Nucleic Acids 48 CIPN 48 Cleft Palate Craniofacial 48 American Thoracic Society 48 ELACYT 48 phase IIb 48 NEJM 48 American Physiological Society 48 AASLD Meeting 48 CLARITY TIMI 48 GnRH agonists 48 journal Urology 48 Randomized Phase III 48 Vascular Biology 48 ALLHAT 48 HORIZONS AMI 48 Radiation Therapy Oncology 48 DMIST 48 ICON7 48 Oncology 48 Wadih Arap 48 Clinical Psychopharmacology 48 Infectious Diseases ECCMID 48 CRLX# 48 Xinlay 48 Phase III VISTA 48 Respiratory Viral Infections 48 trastuzumab DM1 48 preoperative chemotherapy 48 Stenting Trial CREST 48 Nexavar sorafenib 48 gemcitabine 48 meta analysis pooling 48 APOPTONE 48 Aflibercept 48 heavily pretreated 48 Virulizin ® 47 HyQ 47 Hepatology journal published 47 JNCI 47 SPIRIT FIRST 47 ASA# 47 metaglidasen 47 malignant growths 47 evaluating REVLIMID 47 Neurological Surgeons AANS 47 Renata Pasqualini 47 Sangamo BioSciences Announces 47 Screening Trial DMIST 47 Lung Cancer IASLC 47 FFR guided treatment 47 aromatase inhibitors AIs 47 pazopanib 47 HIF PHI 47 Cancer Research 47 J Clin Oncol 47 BRAF inhibitor 47 imetelstat 47 Preclinical Study 47 th Annual Interscience 47 tanespimycin 47 Annual Interscience Conference 47 sorafenib Nexavar 47 multicenter clinical 47 EUROGIN 47 Surgical Oncology 47 everolimus eluting stent 47 iclaprim 47 chemoradiation 47 ovarian suppression 47 temozolomide 47 Clinical Oncology ASCO Gastrointestinal 47 EOquin TM 47 unresectable tumors 47 Urology EAU 47 angiogenesis inhibitor 47 DASISION 47 Pediatric Academic Society 47 CT Colonography 47 Annual ICAAC 47 PEG SN# 47 number NCT# ClinicalTrials.gov 47 ACR ARHP Annual 47 EURIDIS 47 Gastrointestinal Oncology 47 EASD 47 Cellular Immunology 47 antiplatelet therapy 47 oral deforolimus 47 CIMZIA TM certolizumab pegol 47 ALCL 47 Colposcopy 47 Azedra 47 AAO HNSF Annual Meeting 47 recurrent GBM patients 47 iPrEx study 47 Cervical Pathology 47 Immunology Annual Meeting 47 NSCLC 47 Cancer Institute 47 eltrombopag 47 Surgical Oncology SSO 47 rivaroxaban Xarelto 47 Gene Therapy ASGT 47 Phase III psoriasis 47 Malignant Lymphoma 47 chemoprevention 47 elotuzumab 47 PSA screening 47 Lancet Oncology journal 47 prostate cancer HRPC 47 ZD# [001] 47 lymph node involvement 47 Ophthalmology ARVO 47 ASCO Gastrointestinal Cancers Symposium 47 dutasteride 47 gastrointestinal malignancies 47 TASKi2 47 TAXUS IV 47 Erbitux 47 lipid lowering drugs 47 Zolinza 47 BARI 2D 47 Intervention Effectiveness 47 Bipolar Disorders 47 picoplatin 47 Heart Rhythm 47 Recurrent Chest Wall 47 resected pancreatic cancer 47 Pharmacoepidemiology 47 CLEO QELS 47 metastatic hormone refractory 47 Boceprevir 47 ImmunoVEX HSV2 47 Herceptin 47 Gastroenterology ACG Annual 47 intravenous bisphosphonates 47 Solid Tumors 47 SYNTAX trial 47 ON #.Na 47 Gynecologic Oncologists SGO 47 randomized trials 47 Circulation Cardiovascular Interventions 47 Folfox 47 substudy 47 trastuzumab Herceptin ® 47 metastatic renal cell carcinoma 47 trabectedin 47 multicenter prospective 47 ACCOMPLISH 47 Cloretazine ® 47 PROTECT II 47 oral bisphosphonates 47 colon tumors 47 Cytopathology 47 Mass Spectrometry ASMS 47 Multiple Myeloma 47 everolimus eluting stents 47 gynecologic cancer 47 xenograft models 47 CLL8 47 chemopreventive agent 47 ipilimumab 47 AAAAI Annual Meeting 47 journal Menopause 47 HCV Protease Inhibitor 47 adjuvant chemotherapy 47 pharmacokinetic PK 47 journal Cancer Epidemiology 47 BOLDER II 47 MADIT II 47 Ovarian Cancer Screening 47 tamoxifen 47 CAMMS# 47 Clinical Endocrinologists AACE 47 metastatic colorectal cancer 47 Aesthetic Plastic Surgery ASAPS 47 lapatinib 47 CCX# 47 journal Oncogene 47 Neuropsychopharmacology 47 FTY# 47 Aggressive Reduction 47 CIBMTR 47 vandetanib 47 PROLARIS 47 rALLy trial 47 Developmental Therapeutics Immunotherapy 47 figitumumab 47 Randomized Phase 47 dabigatran 47 ESTRO 47 Lapatinib 47 Lancet Neurology 47 CYT# potent vascular disrupting 47 Proellex TM 47 TTF Therapy 47 multicenter Phase II 47 Avastin 47 breast cancer subtypes 47 sirolimus eluting stents 47 fidaxomicin Phase 3 46 Prospective Multicenter 46 Medscape Oncology 46 undergone radical prostatectomy 46 vismodegib 46 Molecular Origins 46 depsipeptide 46 Cancer EORTC 46 randomized clinical trials 46 lexidronam injection 46 atacicept 46 Oral Fingolimod 46 CALGB # [002] 46 SBRT 46 postoperative mortality 46 journal Antimicrobial Agents 46 STRIDE PD 46 Dasatinib 46 gastrointestinal stromal tumors GIST 46 entitled Synergistic 46 Sipuleucel T 46 axitinib 46 Liver Transplantation journal 46 levosimendan 46 vascular disrupting agent 46 ustekinumab 46 Pharmacoeconomic 46 Amrubicin 46 Phase Ib clinical 46 PROSTVAC VF 46 PEARL HF 46 Cristofanilli 46 metastatic melanoma 46 Tanespimycin 46 resistant hormone refractory 46 Geriatric Oncology 46 entinostat 46 nonrandomized studies 46 CUSTOM III 46 KRAS variant 46 vinca alkaloid 46 endometrial hyperplasia 46 Anticancer Drugs 46 CA4P 46 CBLC# 46 Cardiovascular Disease Epidemiology 46 Zarnestra 46 acute PAO 46 AACR symposium 46 journal Arteriosclerosis Thrombosis 46 peritoneal cancer 46 Hematological Malignancies 46 hormone refractory metastatic prostate 46 Kantarjian 46 adjuvant radiotherapy 46 obatoclax 46 Abiraterone 46 Cambridge Healthtech Institute 46 MERIT ES 46 ABSORB 46 AstraZeneca Arimidex 46 prelicensure 46 NASDAQ SLXP today 46 telcagepant 46 TARGIT 46 Chronic Lymphocytic Leukemia 46 ErbB2 positive 46 NCCTG 46 Drugs Affecting Lipid 46 riociguat 46 NCCN guidelines 46 dasatinib 46 EUS FNA 46 phase IIa clinical 46 EGEN 46 journal Diabetologia 46 Bowel Project NSABP 46 Clinical Gastroenterology 46 International Papillomavirus 46 Hedgehog Pathway Inhibitor 46 #th Annual Retrovirus 46 CYPHER Stent 46 LUX Lung 46 SUTENT ® 46 liver metastases 46 ALN TTR 46 nonsmall cell lung cancer 46 trastuzumab DM1 T DM1 46 EuroIntervention 46 Pharmacological Research 46 Caris Dx 46 Hepatology journal 46 ASCO abstract 46 journal Resuscitation 46 Avodart 46 chronic lymphocytic leukemia CLL 46 Cardiac Failure 46 Deforolimus 46 PROVENGE sipuleucel T 46 KRAS mutation 46 sentinel node biopsy 46 Gemzar ® 46 ACCORD Lipid 46 mCRC patients 46 recurrent glioma 46 stent DES 46 tolvaptan 46 Tarvacin 46 HIV HCV coinfected 46 EBUS FNA 46 Neurosurgery Spine 46 vorinostat 46 pelvic malignancies 46 MDV# 46 Movement Disorder 46 eribulin 46 Relapsed Multiple Myeloma 46 Chronic Hepatitis C 46 Annual BIO 46 Cardiovascular Research 46 HeFT 46 confirmatory clinical 46 FOLFOX6 chemotherapy regimen 46 ductal carcinomas 46 Neurological Surgeons 46 Br J Haematol 46 adjuvant therapy 46 Geriatric Society 46 BioNumerik 46 European Randomized Study 46 Arimidex anastrozole 46 AACR EORTC NCI 46 Laheru 46 Dr. Kandzari 46 superficial bladder cancer 46 Daniel Von Hoff 46 Renal Cell Carcinoma 46 Cancer AACR NCI 46 Urocortin 2 46 flavopiridol 46 venous thromboembolism 46 Rivaroxaban 46 Hodgkin lymphoma HL 46 BJU International 46 Preclinical Data 46 Experimental Dermatology 46 Acute Heart Failure 46 neoadjuvant 46 Faslodex 46 Am J Pathol 46 cabazitaxel 46 Clinical Efficacy 46 Zoledronic acid 46 Vectibix 46 INGN 46 ALTTO 46 Aplidin 46 Cotara 46 Cardiology ESC Congress 46 refractory multiple myeloma 46 Cancer Immunology Immunotherapy 46 Cytokinetics Incorporated NASDAQ CYTK 46 endometriosis ovarian cysts 46 Cochrane Systematic Review 46 Cardiovascular Angiography 46 Revlimid 46 Professional Sleep Societies 46 APPRAISE 46 Phase III placebo controlled 46 ClinicalTrials.gov 46 ASM Biodefense 46 randomized discontinuation trial 46 NovoTTF 46 Nephrology ASN 46 AVAiL 46 Human Molecular Genetics 46 nonmelanoma skin cancers 46 Fifth Decennial International 46 Radiological Society 46 Human Brain Mapping 46 Proteome Research 46 RE LY ® 46 Ann Oncol 46 Dendritic Cells 46 oral rivaroxaban 46 Neulasta ® 46 NATRECOR ® 46 journal Obstetrics 46 Dr. Gulfo 46 Cardiovascular Anesthesiologists 46 Microbicide 46 metastatic CRC 46 Cardiology 46 Severe Sepsis 46 Oncology ESTRO 46 HYVET 46 mg administered orally 46 Val HeFT 46 XL# SAR# 46 Subgroup analyzes 46 Vulnerable Plaque 46 aldosterone antagonists 46 AIM HIGH 46 DU #b 46 Castration Resistant Prostate Cancer 46 Vandetanib 46 NCIC CTG 46 metastatic RCC 46 Nephrology Dialysis Transplantation 46 Allovectin 7 ® 46 glufosfamide 45 NASDAQ CYTK announced 45 MEND CABG 45 HRPC 45 ACC.# 45 cervical lesions 45 Long Awaited Reality 45 Cholesterol Levels SPARCL 45 AA Amyloidosis 45 ISEL 45 Human Gene Therapy 45 afatinib 45 journal Immunity 45 Reproductive Medicine ASRM 45 zanolimumab 45 Breast Imaging 45 ERA EDTA 45 ProSavin 45 Zheng Cui 45 Thrombosis 45 Environ Health Perspect 45 Clin Chem 45 ASCRS 45 rALLy 45 Lung Transplantation 45 percutaneous cryoablation 45 Trial NLST 45 Zemplar Capsules 45 multiple myeloma 45 JAIDS 45 Physiology Endocrinology 45 Hematologic 45 Novartis Gleevec 45 antiplatelet 45 Neuvenge 45 Clinical Antipsychotic Trials 45 ovarian lung 45 NABTT 45 Keystone Symposia 45 journal Nature Chemical Biology 45 Hepatocellular Carcinoma HCC 45 HGS ETR1 45 Novel Therapies 45 Ambulatory Pediatrics 45 Acute Stroke 45 Pooled Analysis 45 colorectal cancer 45 INCB# [001] 45 anthracycline taxane 45 Vertex telaprevir 45 Survival Benefit 45 journal Lancet 45 Velcade 45 journal PLoS Pathogens 45 medically inoperable 45 Microbiology ASM 45 Geriatric Psychiatry 45 Br J Cancer 45 KRAS mutations 45 Proxinium TM 45 oral proteasome inhibitor 45 Multicenter 45 Erbitux cetuximab 45 gastrointestinal stromal tumor GIST 45 ASHG 45 CR# vcMMAE 45 Abstract Number 45 Hsp# Inhibitor 45 VADT 45 preclinically 45 neoadjuvant chemotherapy 45 Randomized Phase II 45 Methodist DeBakey Heart 45 Combination therapy 45 relapsed SCLC 45 randomized controlled clinical 45 colorectal adenomas 45 Poster Session 45 brain metastases 45 Pirfenidone 45 recurrent metastatic 45 ZYBRESTAT 45 Epilepsy Society 45 seliciclib 45 adecatumumab 45 AIR2 Trial 45 Sym# 45 ANN INTERN MED 45 diagnosed multiple myeloma 45 Romidepsin 45 scientific journal Proceedings 45 Double Blind Placebo 45 AACR Symposium 45 Molecular Therapy 45 Trastuzumab DM1 45 anastrozole Arimidex 45 farletuzumab 45 Bladder Cancer 45 relapsing remitting multiple sclerosis 45 mutated KRAS gene 45 Clinical Endocrinology & 45 CHARISMA trial 45 warfarin dosing 45 FASLODEX 45 Plastic Surgeons ASPS 45 gefitinib Iressa 45 Catheterization 45 Cetuximab 45 Patient Outcomes 45 ovarian cancer 45 Retina Specialists ASRS 45 Nasdaq DNDN 45 ISHLT 45 Paroxysmal Nocturnal Hemoglobinuria PNH 45 Bapineuzumab 45 carfilzomib 45 J Natl Cancer Inst 45 Biodefense Vaccines 45 Gynecol Oncol 45 CTAP# Capsules 45 cabozantinib 45 ovarian endometrial 45 Ixempra 45 Menopause Society NAMS 45 AVN# Phase 45 Genasense ® 45 phase IIb study 45 Medtronic Endeavor stent 45 Cardiovascular Interventions 45 EMBO J. 45 randomized multicenter trial 45 PARTNER Trial 45 EULAR Annual 45 ALN VSP 45 statins 45 CIMZIA ™ 45 Phase III ADT 45 Ridker 45 adenoma recurrence 45 ongoing Phase IIIb 45 gemcitabine Gemzar